• Explore /
  • Poster
  • / <em fontscheme="2">POLE</em><span fontscheme="2"> variant phenotypic classification to enable identification of patients with colorectal cancer (CRC) who may benefit from immune checkpoint inhibition (ICI).</span>

POLE variant phenotypic classification to enable identification of patients with colorectal cancer (CRC) who may benefit from immune checkpoint inhibition (ICI).

Abstract Poster

Authors

Rachel Keller-Evans

Rachel Beth Keller

Foundation Medicine, Inc., Cambridge, MA

Rachel Beth Keller , Zoe Fleischmann , Smruthy Sivakumar , Radwa Sharaf , Tyler Janovitz , Alexa B. Schrock , Hanna Tukachinsky , Lei Zhong , Douglas A. Mata , Lyle Lopez , Ethan Sokol , Garrett M. Frampton , Douglas I. Lin , Geoffrey R. Oxnard , Erik A. Williams , Julia A. Elvin , Brennan J. Decker

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 194)

DOI

10.1200/JCO.2024.42.3_suppl.194

Abstract #

194

Poster Bd #

M2

Abstract Disclosures

Similar Posters

First Author: Ting Xu

First Author: Celine Yeh

First Author: Yoshiaki Nakamura

First Author: Fiyinfolu Balogun